SightfileU.S. market data from official filings

iSpecimen Inc (ISPC)

Name: iSpecimen Inc (ISPC) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001558569 · EDGAR filings · Updated 2026-07-17

iSpecimen Inc (ISPC) has reported institutional ownership of 1.8%, with 11 institutional managers holding positions valued at $83.5K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings, triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Institutional ownership

1.8%

Institutional managers

Reported 13F value

$83.5K

Data flags

3 active

from SEC filings

Latest updates

2026-07-17 — S-1/A filed
2026-07-14 — Current report (8-K) filed
2026-07-06 — S-1/A filed
2026-06-24 — Registration statement (S-1) filed
2026-06-22 — DRS/A filed
2026-06-17 — EFFECT filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, iSpecimen Inc has 11 institutional holders and institutional ownership of 1.8%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-06-01 (recurring since 2023-10-10) — source filing. The authoritative details are those stated in the filing itself.

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-18 (recurring since 2021-08-10) — source filing. The authoritative details are those stated in the filing itself.

Active triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04), most recently filed 2022-04-29 (recurring since 2022-04-29) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Co-Diagnostics Inc (CODX) · PLURI INC (PLUR) · CYTODYN INC (CYDY) · MetaVia Inc (MTVA) · NUCANA PLC (NCNA) · FUNCTIONAL BRANDS INC (MEHA)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.